<DOC>
	<DOCNO>NCT00881517</DOCNO>
	<brief_summary>The aim trial verify , control condition , report efficacy human cytomegalovirus ( HCMV ) -specific hyperimmune globulin administration pregnant woman suffer primary HCMV infection prevention intrauterine HCMV transmission .</brief_summary>
	<brief_title>Efficacy Study Human Cytomegalovirus ( HCMV ) Hyperimmune Globulin Prevent Congenital HCMV Infection</brief_title>
	<detailed_description>HCMV lead infectious cause mental retardation deafness infant congenital HCMV infection . Primary HCMV infection pregnancy carry high risk fetal infection disease . No intervention proven efficacy available case primary HCMV infection pregnancy . However , study publish 2005 ( Nigro et al. , NEJM 353:1350-62 , 2005 ) report pregnant woman primary HCMV infection treat HCMV-specific hyperimmune globulin ( Cytotect® , Biotest ) risk transmit infection fetus reduce 40 % 16 % . Unfortunately , since study conduct inadequate control , actual efficacy hyperimmune globulin could properly assess . In present randomize , double-blind , placebo-controlled , multicenter trial pregnant woman ascertain primary HCMV infection 4-26 week gestation randomize receive Cytotect® placebo intravenously within 6 week presume onset infection . Primary efficacy parameter number HCMV-infected newborns fetus .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<criteria>pregnant woman ( vitro fertilization permit ) &gt; = 18 year age primary HCMV infection 526 week ' gestation &lt; = 6 week presume onset infection gestational age 532 week ' gestation write informed consent multiple pregnancy history HIV HBV HCV infection know immunodeficiency immunosuppression congenital acquire autoimmune disease know intolerance protein human origin know intolerance immune globulin history adverse effect vaccination hypersensitivity human immune globulin ( pathological IgG IgA deficiences ) renal failure serious organic psychiatric disease lack motivation participate study woman unable satisfy study requirement woman willing unable provide write informed consent woman willing give consent transmission anonymised data</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>human cytomegalovirus</keyword>
	<keyword>immune globulin</keyword>
	<keyword>congenital infection</keyword>
	<keyword>prevention</keyword>
	<keyword>pregnancy</keyword>
</DOC>